View BioLineRX Ltd. Sponsored ADR BLRX stock quote prices, financial information, real-time forecasts, and company news from CNN.
BioLineRx's EDP-14, for Treatment of Severe and Persistent Asthma, to Enter the Company's Main Thera
BioLineRx's EDP-14, for Treatment of Severe and Persistent Asthma, to Enter the Company's Main Therapeutic Pipeline as BL-9010 JERUSALEM--(BUSINESS WIRE)-- BioLineRx (NAS: BLRX) (TASE: BLRX), a ...
Initiation of a Phase I/IIa first-in-human trial for GLIX1 in glioblastoma (GBM) was announced, with the first patient dosed at NYU Langone Health; two additional academic centers (Northwestern ...
TEL AVIV, Israel, May 20, 2025 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, ...
InvestorsHub on MSN
BioLineRx shares advance after first patient enrolled in GLIX1 cancer study (BLRX)
BioLineRx Ltd. (NASDAQ:BLRX) reported first-quarter 2026 financial results on Wednesday, shortly after announcing that the ...
TEL AVIV, Israel, Nov. 18, 2025 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases ...
Bioline RX Ltd Sponsored ADR ( (BLRX)) has released its Q3 earnings. Here is a breakdown of the information Bioline RX Ltd Sponsored ADR presented to its investors. Unlock your investing potential ...
TEL AVIV, Israel, and OSLO, Norway, April 28, 2026 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies ...
TEL AVIV, Israel and OSLO, Norway, May 19, 2026 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in ...
Detailed price information for Biolinerx Ltd ADR (BLRX-Q) from The Globe and Mail including charting and trades.
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its unaudited financial results ...
TEL AVIV, Israel, Sept. 3, 2019 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today that it has successfully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results